VKTX icon

Viking Therapeutics
VKTX

Overview Fund Activity

140 hedge funds and large institutions have $92.8M invested in Viking Therapeutics in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
140
Holders Change
–
Holders Change %
0%
% of All Funds
2.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
46
Reduced
34
Closed
19
Calls
$1.06M
Puts
$637K
Net Calls
+$425K
Net Calls Change
-$1.77M

Top Buyers

1
Millennium Management
Millennium Management
New York
$4.51M
2
PWAM
Park West Asset Management
California
$7.41M
3
Renaissance Technologies
Renaissance Technologies
New York
$2.9M
4
Citadel Advisors
Citadel Advisors
Florida
$1.84M
5
SCM
Sio Capital Management
New York
$3M

Top Sellers

1
ACH
ArrowMark Colorado Holdings
Colorado
$54K
2
State Street
State Street
Massachusetts
$4.07M
3
Nuveen Asset Management
Nuveen Asset Management
Illinois
$855K
4
Rafferty Asset Management
Rafferty Asset Management
New York
$0
5
UBS Group
UBS Group
Switzerland
$229K
Name Holding Trade Value Shares
Change 		Shares
Change %
MIFH
151
Migdal Insurance & Financial Holdings
Israel
– -$6K -1,200 Closed
CFGS
152
Concourse Financial Group Securities
Alabama
– -$1K -200 Closed
3 4 5 6
7